Hanatani Y, Kobayashi H, Kodaira S, Takami H, Asagoe T, Kaneshiro E
First Department of Surgery, Teikyo University School of Medicine, Itabashi-ku, Tokyo 173-8605, Japan.
Oncol Rep. 2000 Sep-Oct;7(5):1027-33. doi: 10.3892/or.7.5.1027.
Collagen gel droplet embedded culture drug sensitivity test (CD-DST) was applied to 33 patients with gastric cancer (30 primary tumors, 12 metastatic tumors and 25 biopsy specimens). Evaluable rates by CD-DST were 80% for primary tumors, 75% for metastatic tumors and 72% for biopsy specimens. Chemosensitivities of primary tumors were: 5-fluorouracil 25%, mitomycin C 17%, cisplatin 13%, adriamycin 17%, etoposide 21%. Chemosensitivities of metastatic tumors were lower than those of primary tumors. In 4 out of 6 patients who had measurable lesions, clinical responses to chemotherapy were predictable by CD-DST.
将胶原凝胶微滴包埋培养药物敏感性试验(CD-DST)应用于33例胃癌患者(30例原发性肿瘤、12例转移瘤和25份活检标本)。CD-DST对原发性肿瘤的可评估率为80%,对转移瘤为75%,对活检标本为72%。原发性肿瘤的化疗敏感性为:5-氟尿嘧啶25%,丝裂霉素C 17%,顺铂13%,阿霉素17%,依托泊苷21%。转移瘤的化疗敏感性低于原发性肿瘤。在6例有可测量病变的患者中,有4例患者对化疗的临床反应可通过CD-DST预测。